期刊
STRAHLENTHERAPIE UND ONKOLOGIE
卷 197, 期 1, 页码 48-55出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00066-020-01689-7
关键词
Radiation dermatitis; Acute toxicity; Intensity modulated radiotherapy; Treatment compliance; Adverse events
资金
- Projekt DEAL
This study demonstrated low toxicity and high treatment adherence of moderately accelerated hypofractionated radiotherapy with a simultaneous integrated boost in a multicenter prospective trial, despite not meeting the primary hypothesis.
Purpose We report results of a multicenter prospective single-arm phase II trial (ARO-2013-04, NCT01948726) of moderately accelerated hypofractionated radiotherapy with a simultaneous integrated boost (SIB) in patients with breast cancer receiving adjuvant radiotherapy after breast-conserving surgery. Methods The eligibility criteria included unifocal breast cancer with an indication for adjuvant radiotherapy to the whole breast and boost radiotherapy to the tumor bed. The whole breast received a dose of 40Gy and the tumor bed a total dose of 48Gy in 16 fractions of 2.5 and 3Gy, respectively. Radiotherapy could be given either as 3D conformal RT (3D-CRT) or as intensity-modulated radiotherapy (IMRT). The study was designed as a prospective single-arm trial to evaluate the acute toxicity of the treatment regimen. The study hypothesis was that the frequency of acute skin reaction grade >= 2 would be 20% or less. Results From November 2013 through July 2014, 149 patients were recruited from 12 participating centers. Six patients were excluded, leaving 143 patients for analysis. Eighty-four patients (58.7%) were treated with 3D-CRT and 59 (41.3%) with IMRT. Adherence to the treatment protocol was high. The rate of grade >= 2 skin toxicity was 14.7% (95% confidence interval 9.8-21.4%). The most frequent grade 3 toxicity (11%) was hot flashes. Conclusion This study demonstrated low toxicity of and high treatment adherence to hypofractionated adjuvant radiotherapy with SIB in a multicenter prospective trial, although the primary hypothesis was not met.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据